Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Body Weight and CYP2C19[original query] |
|---|
| The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients. Journal of clinical psychopharmacology 2002 Aug 22 (4): 371-8. Shimoda Kazutaka, Someya Toshiyuki, Yokono Aya, Morita Sachiyo, Hirokane Genta, Takahashi Saburo, Okawa Masa |
| The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients. Journal of clinical psychopharmacology 2001 Dec 21 (6): 549-55. Yokono A, Morita S, Someya T, Hirokane G, Okawa M, Shimoda |
| [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. Zhonghua yi xue za zhi 2004 Oct 84 (20): 1686-9. Huang Yue, Yang Jing-Fang, Qi Xiao-Lian, Wang Yu-Qin, Wang Wei-Zhi, Chen Bi |
| Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese. Therapeutic drug monitoring 2007 Feb 29 (1): 118-21. Goto Shuji, Seo Takayuki, Murata Tsukasa, Nakada Naoyuki, Ueda Nao, Ishitsu Takateru, Nakagawa Kazu |
| Population estimation regarding the effects of cytochrome P450 2C19 and 3A5 polymorphisms on zonisamide clearance. Therapeutic drug monitoring 2008 Aug 30 (4): 540-3. Okada Yusuke, Seo Takayuki, Ishitsu Takateru, Wanibuchi Atsuko, Hashimoto Nami, Higa Yoko, Nakagawa Kazu |
| Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients. Therapeutics and clinical risk management 2010 6 265-9. Katsakiori Paraskevi F, Papapetrou Eirini P, Goumenos Dimitrios S, Nikiforidis George C, Flordellis Christodoulos |
| Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures. Archives of disease in childhood 2012 Jun 97 (6): 569-72. Lee Soon Min, Chung Jae Yong, Lee Young Mock, Park Min Soo, Namgung Ran, Park Kook In, Lee Ch |
| Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers. Clinical drug investigation 2012 Nov . Jiang T, Rong Z, Xu Y, Chen B, Xie Y, Chen C, Lu Y, Shen Y, Li H, Sun J, Chen H |
| Influence of CYP2C19 polymorphism and concomitant antiepileptic drugs on serum clobazam and N-desmethyl clobazam concentrations in patients with epilepsy. Therapeutic drug monitoring 2013 Jun 35 (3): 305-12. Yamamoto Yoshiaki, Takahashi Yukitoshi, Imai Katsumi, Miyakawa Kou, Nishimura Shigeko, Kasai Risa, Ikeda Hiroko, Takayama Rumiko, Mogami Yukiko, Yamaguchi Tokito, Terada Kiyohito, Matsuda Kazumi, Inoue Yushi, Kagawa Yoshiyu |
| Individualized phenytoin therapy for Japanese pediatric patients with epilepsy based on CYP2C9 and CYP2C19 genotypes. Therapeutic drug monitoring 2015 Apr 37 (2): 229-35. Yamamoto Yoshiaki, Takahashi Yukitoshi, Imai Katsumi, Miyakawa Kou, Ikeda Hiroko, Ueda Yuki, Yamaguchi Tokito, Nasu Hirosato, Ohtani Hideyuki, Shigematsu Hideo, Kagawa Yoshiyuki, Inoue Yus |
| CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy. European journal of clinical pharmacology 2015 Apr 71 (4): 433-9. Chang Ming, Söderberg Mao Mao, Scordo Maria Gabriella, Tybring Gunnel, Dahl Marja-Lii |
| Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine. Clinical pharmacokinetics 2017 05 56 (5): 525-536. Green Bruce, Crauwels Herta, Kakuda Thomas N, Vanveggel Simon, Brochot An |
| Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients. British journal of clinical pharmacology 2018 Apr . Lin Xiao-Bin, Li Zi-Wei, Yan Miao, Zhang Bi-Kui, Liang Wu, Wang Feng, Xu Ping, Xiang Da-Xiong, Xie Xu-Biao, Yu Shao-Jie, Lan Gong-Bin, Peng Feng-H |
| Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression. Therapeutic drug monitoring 2018 Mar . Tsuchimine Shoko, Ochi Shinichiro, Tajiri Misuzu, Suzuki Yutaro, Sugawara Norio, Inoue Yoshimasa, Yasui-Furukori Nor |
| High voriconazole target-site exposure after approved sequence dosing due to nonlinear pharmacokinetics assessed by long-term microdialysis. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 2 131 218-229. Kirbs Claudia, Kluwe Franziska, Drescher Franziska, Lackner Edith, Matzneller Peter, Weiss Johanna, Zeitlinger Markus, Kloft Charlot |
| Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy. European journal of hospital pharmacy : science and practice 2020 Aug . Song Cangsang, Li Xingde, Mao Panpan, Song Wenbing, Liu Lu, Zhang Ya |
| Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance. European journal of clinical pharmacology 2020 Jul . Li Zhiqiang, Dong Wanqing, Yang Daorong, Sun Linhai, He Xianjun, Hu Huanhuan, Zhang Jianping, Wang Chunyu, Li Yulin, Zhao Ming, Kong Yu, Wang Y |
| Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention. International journal of cardiology 2020 11 327 15-18. Saito Yuichi, Nishi Takeshi, Wakabayashi Shinichi, Ohno Yuji, Kitahara Hideki, Ariyoshi Noritaka, Kobayashi Yosh |
| Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer. Clinical pharmacology and therapeutics 2020 Oct . Puszkiel Alicja, Arellano Cécile, Vachoux Christelle, Evrard Alexandre, Le Morvan Valérie, Boyer Jean-Christophe, Robert Jacques, Delmas Caroline, Dalenc Florence, Debled Marc, Venat-Bouvet Laurence, Jacot William, Dohollou Nadine, Bernard-Marty Chantal, Laharie-Mineur Hortense, Filleron Thomas, Roché Henri, Chatelut Etienne, Thomas Fabienne, White-Koning Melan |
| Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Molecular diagnosis & therapy 2021 8 25 (6): 735-755. Hirata Thiago Dominguez Crespo, Dagli-Hernandez Carolina, Genvigir Fabiana Dalla Vecchia, Lauschke Volker Martin, Zhou Yitian, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Cres |
| Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population. Pharmaceuticals (Basel, Switzerland) 2021 4 14 (3): . Barnett Shelby, Errington Julie, Sludden Julieann, Jamieson David, Poinsignon Vianney, Paci Angelo, Veal Gareth |
| A Population Pharmacokinetic Meta-Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients. Journal of clinical pharmacology 2021 Apr . Stodtmann Sven, Nuthalapati Silpa, Eckert Doerthe, Kasichayanula Sreeneeranj, Joshi Rujuta, Bach Bruce A, Mensing Sven, Menon Rajeev, Xiong H |
| Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study. BMC medicine 2022 7 20 (1): 261. Ricardo-Silgado Maria L, Singh Sneha, Cifuentes Lizeth, Decker Paul A, Gonzalez-Izundegui Daniel, Moyer Ann M, Hurtado Maria D, Camilleri Michael, Bielinski Suzette J, Acosta Andr |
| Establishment of a mathematical prediction model for voriconazole stable maintenance dose: a prospective study. Frontiers in cellular and infection microbiology 2023 8 13 1157944. Lijuan Zhou, Min Li, Huihong Li, Zhiqiang Guo, Yanqiu Gao, Hua Zhang, Fuli Qin, Zhihui Sang, Qinghe Xing, Long Cheng, Wei C |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: